Association of Methionine Synthase Rs1801394 and Methionine Synthase Reductase Rs1805087 Polymorphisms with Meningioma in Adults: A Meta-analysis

Overview

Journal Biomed Rep

Specialty Biochemistry

Date 2014 Apr 22

PMID 24748989

Citations 5

Authors

Xian-Tao Zeng

Jun-Ti Lu

Xiang-Jun Tang

Hong Weng

Jie Luo

Affiliations

Soon will be listed here.

Abstract

Several epidemiological studies suggested that methionine synthase (MTRR) rs1801394 and methionine synthase reductase (MTR) rs1805087 polymorphisms may be involved in the risk of meningioma in adults; however, the results from different case-control studies have been inconsistent. Therefore, we performed a meta-analysis to investigate the association of MTRR and MTR polymorphisms with meningioma. PubMed, Web of Knowledge, China National Knowledge Infrastructure and Wanfang databases were searched up to October 30, 2013 and 3 publications, involving 7 case-control studies, were finally included. Following data extraction, a meta-analysis was conducted using Stata 12.0 software. The pooled results based on the fixed effects model demonstrated that the MTRR rs1801394 polymorphism was associated with an increased risk of meningioma [odds ratio (OR)=1.18, 95% confidence interval (CI): 1.05-1.32 for G vs. A; OR=1.41, 95% CI: 1.12-1.77 for GG vs. AA; OR=1.08, 95% CI: 0.94-1.33 for AG vs. AA; OR=1.19, 95% CI: 1.01-1.40 for (AG+GG) vs. AA; and OR=1.32, 95% CI: 1.07-1.63 for GG vs. (AG+AA)]; however, an association between the MTR rs1805087 polymorphism and the risk of meningioma was not identified [OR=0.99, 95% CI: 0.88-1.12 for G vs. A; OR=1.09, 95% CI: 0.80-1.48 for GG vs. AA; OR=0.95, 95% CI: 0.82-1.11 for AG vs. AA; OR=0.97, 95% CI: 0.84-1.13 for (AG+GG) vs. AA; and OR=1.09, 95% CI: 0.80-1.48 for GG vs. (AG+AA)]. Therefore, the currently available evidence suggests that the MTRR rs1801394 polymorphism may increase the risk of meningioma, whereas the MTRR rs1801394 polymorphism is not associated with meningioma.

Citing Articles

Investigation of the relationship between MTRR A66G, MTR A2756G gene variations and cell anomalies in early diagnosis and progression of bladder cancer.

Alkanli N, Ay A, Koroglu Aydin P, Cevik G Mol Biol Rep. 2022; 49(8):7719-7729.

PMID: 35715601 DOI: 10.1007/s11033-022-07597-6.

Association of Single Nucleotide Polymorphisms (SNPs) in Genes Encoding for Folate Metabolising Enzymes with Glioma and Meningioma in Indian Population.

Kumawat R, Gowda S, Debnath E, Rashid S, Niwas R, Gupta Y Asian Pac J Cancer Prev. 2018; 19(12):3415-3425.

PMID: 30583664 PMC: 6428555. DOI: 10.31557/APJCP.2018.19.12.3415.

Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults.

Chen D, Dong J, Huang Y, Gao F, Yang X, Gong X Oncotarget. 2017; 8(34):57265-57277.

PMID: 28915669 PMC: 5593640. DOI: 10.18632/oncotarget.18986.

Genetic variants and increased risk of meningioma: an updated meta-analysis.

Han X, Wang W, Wang L, Wang X, Li G Onco Targets Ther. 2017; 10:1875-1888.

PMID: 28405167 PMC: 5378443. DOI: 10.2147/OTT.S130147.

Genetic association between interluekin-4 rs2243250 polymorphism and gastric cancer susceptibility: evidence based on a meta-analysis.

Zhang C, Huang J, He Z, Weng H Onco Targets Ther. 2016; 9:2403-8.

PMID: 27143935 PMC: 4844435. DOI: 10.2147/OTT.S104181.

References

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lonn S . Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008; 17(5):1195-202. DOI: 10.1158/1055-9965.EPI-07-2733. View

Olteanu H, Munson T, Banerjee R . Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002; 41(45):13378-85. DOI: 10.1021/bi020536s. View

Jhawar B, Fuchs C, Colditz G, Stampfer M . Sex steroid hormone exposures and risk for meningioma. J Neurosurg. 2003; 99(5):848-53. DOI: 10.3171/jns.2003.99.5.0848. View

Yu K, Zhang J, Zhang J, Dou C, Gu S, Xie Y . Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis. Eur J Hum Genet. 2009; 18(3):370-8. PMC: 2987221. DOI: 10.1038/ejhg.2009.131. View

Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F . Association of meningioma with reproductive factors. Int J Cancer. 2006; 119(5):1152-7. DOI: 10.1002/ijc.21950. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H . Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 2001; 97(10):3205-9. DOI: 10.1182/blood.v97.10.3205. View

Porter K, McCarthy B, Freels S, Kim Y, Davis F . Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol. 2010; 12(6):520-7. PMC: 2940648. DOI: 10.1093/neuonc/nop066. View

10.

Malmer B, Feychting M, Lonn S, Lindstrom S, Gronberg H, Ahlbom A . Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol. 2006; 82(3):229-37. DOI: 10.1007/s11060-006-9275-1. View

11.

Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B . Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev. 2005; 14(4):969-76. DOI: 10.1158/1055-9965.EPI-04-0366. View

12.

Inskip P, Tarone R, Hatch E, Wilcosky T, Shapiro W, Selker R . Cellular-telephone use and brain tumors. N Engl J Med. 2001; 344(2):79-86. DOI: 10.1056/NEJM200101113440201. View

13.

Phillips L, Koepsell T, van Belle G, Kukull W, Longstreth Jr W . History of head trauma and risk of intracranial meningioma: population-based case-control study. Neurology. 2002; 58(12):1849-52. DOI: 10.1212/wnl.58.12.1849. View

14.

Preston-Martin S, Paganini-Hill A, Henderson B, Pike M, Wood C . Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst. 1980; 65(1):67-73. View

15.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

16.

Xu C, Yuan L, Tian H, Cao H, Chen S . Association of the MTHFR C677T polymorphism with primary brain tumor risk. Tumour Biol. 2013; 34(6):3457-64. DOI: 10.1007/s13277-013-0922-9. View

17.

Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M . Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol. 2006; 164(7):629-36. DOI: 10.1093/aje/kwj254. View

18.

Johansen C, Boice Jr J, McLaughlin J, Olsen J . Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001; 93(3):203-7. DOI: 10.1093/jnci/93.3.203. View

19.

Ron E, Modan B, Boice Jr J, Alfandary E, Stovall M, Chetrit A . Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988; 319(16):1033-9. DOI: 10.1056/NEJM198810203191601. View

20.

Lai R, Crevier L, Thabane L . Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005; 14(7):1784-90. DOI: 10.1158/1055-9965.EPI-05-0105. View